Prof. Martin Bögemann is Associate Professor of Urology, Senior Physician in Uro-oncology, and Head of the Clinical Trial Unit of the Department of Urology at Münster University Hospital (Universitätsklinikum Münster) in Münster, Germany.
A medical specialist in urology and uro-oncology, Prof. Bögemann’s research focus includes castration resistance in prostate cancer, tumour markers and tumour-marker dynamics, real world application of cancer drugs, palliative care/quality of life medicine, and translational research with regards to liquid biopsy.
Prof. Bögemann acts (or has acted) as principal investigator in numerous clinical trials related to transitional cell carcinoma, renal cell carcinoma and castration resistant prostate cancer (CRPC).
He has published extensively in his specialized field of medicine, and is a member of several national scientific societies (including the German Society of Urology [Deutsche Gesellschaft für Urologie; DGU], the German Cancer Society [Deutsche Krebsgesellschaft ;DKG], the German Society for Residents in Urology [GeSRU], and the Northrhine Westfalian Society of Urology [Nordrhein-Westfälischen Gesellschaft für Urologie; NRWGU]), and of notable international societies including the European Urology Association (EAU), the American Association for Cancer Research (AACR), and the American Society of Clinical Oncology (ASCO).
EM-14583- Date of preparation: July 2019